https://www.selleckchem.com/pr....oducts/pin1-inhibito
68 vs. 0.53, P0.001). L3SMD improved the identification of low bone mass when added to age, sex, V/S ratio, and L3SMI (category-free net reclassification improvement 0.349, P0.001; integrated discrimination improvement 0.015, P=0.0165). L3SMD can be an early marker for age-related musculoskeletal changes showing linear decline throughout life from the second decade in healthy adults, with potential diagnostic value for individuals with low bone mass. L3SMD can be an early marker for age-related musculoskeletal chang
Like
Comment
Share
